Active	Status	Sponsor type	Region	Phase	Filter
1 Active 0 Inactive 1 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other Show only owner-sponsored trials	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

1 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
HK-001 / Everfront Biotech
NCT03651349: To Determine the Maximum Tolerated Dose (MTD) of HK-001 in Healthy Volunteers	Active, not recruiting	1	56	RoW	HK-001, (Z)-n-butylidenephthalide [(Z)-BP], Placebo control, Placebo	Everfront Biotech Co., Ltd.	Amyotrophic Lateral Sclerosis	12/24	06/25